Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GSK | AZN | AMGN | GILD | BMY |
| Company | Gsk Plc ADR | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 48.85 | 94.47 | 328.70 | 123.80 | 56.46 |
| High | 48.93 | 94.68 | 333.03 | 125.07 | 56.56 |
| Low | 48.09 | 93.51 | 326.90 | 122.10 | 55.17 |
| Latest | 48.28 | 94.14 | 331.01 | 124.12 | 55.21 |
| Change | -0.84 | +0.15 | +0.98 | +2.86 | -1.41 |
| % Change | -1.71% | +0.16% | +0.30% | +2.36% | -2.49% |
| Volume | 5,036,438 | 7,036,787 | 1,748,757 | 3,457,162 | 7,319,030 |
| 20-Day Average Volume | 3,459,875 | 5,434,149 | 2,629,845 | 6,039,175 | 13,958,812 |
| Previous Close | 49.12 | 93.99 | 330.03 | 121.26 | 56.62 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 49.45 | 93.12 | 329.25 | 122.89 | 54.92 |
| 20-Day Raw Stochastic | 9.85% | 69.91% | 57.53% | 72.17% | 69.38% |
| 20-Day Relative Strength | 48.82 | 57.69 | 54.03 | 53.23 | 60.24 |
| Weighted Alpha | +44.30 | +44.46 | +23.14 | +31.59 | +7.31 |
| Today's Opinion | 64% Buy | 100% Buy | 80% Buy | 72% Buy | 100% Buy |
| Previous Opinion | 80% Buy | 100% Buy | 80% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 72% Buy | 56% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.87% since 01/09/26 | -0.25% since 01/09/26 | +1.96% since 01/09/26 | +2.79% since 01/09/26 | -0.62% since 01/09/26 |
| Low | 48.11 on 01/16/26 | 92.78 on 01/13/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 55.33 on 01/15/26 |
| High | 50.87 on 01/14/26 | 96.43 on 01/14/26 | 333.03 on 01/16/26 | 125.07 on 01/16/26 | 57.04 on 01/14/26 |
| 1-Month | |||||
| %Chg | -0.70% since 12/16/25 | +3.35% since 12/16/25 | +1.76% since 12/16/25 | +4.80% since 12/16/25 | +2.37% since 12/16/25 |
| Low | 48.11 on 01/16/26 | 89.53 on 01/05/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 51.46 on 01/06/26 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 57.04 on 01/14/26 |
| 3-Month | |||||
| %Chg | +10.67% since 10/16/25 | +12.62% since 10/16/25 | +12.40% since 10/16/25 | +5.63% since 10/16/25 | +27.94% since 10/16/25 |
| Low | 42.85 on 10/24/25 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 51.46 on 01/06/26 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| 6-Month | |||||
| %Chg | +26.54% since 07/16/25 | +34.72% since 07/16/25 | +11.20% since 07/16/25 | +13.32% since 07/16/25 | +17.69% since 07/16/25 |
| Low | 35.45 on 07/17/25 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 42.52 on 10/29/25 |
| High | 51.46 on 01/06/26 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 100,126,496 | 291,505,472 | 177,714,880 | 150,444,864 | 115,264,336 |
| Shares Outstanding, K | 2,038,406 | 3,101,452 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 40,095,390,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | 3,290,590,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 11,520,500,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | 2,713,320,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 0.45 | 0.34 | 0.45 | 0.33 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.48 on 10/29/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 1.63 on 10/30/25 |
| Latest Earnings Date | 02/04/26 | 02/10/26 | 02/03/26 | 02/10/26 | 02/05/26 |
| Most Recent Dividend | 0.426 on 11/14/25 | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | 11/14/25 | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 11.47 | 21.08 | 15.04 | 15.15 | 8.69 |